Nitric oxide (NO) and glutamate are both important mediators of the central
cardiovascular regulation in the nucleus tractus solitarii. Our previous s
tudies revealed that the central cardiovascular effects of NO in the nucleu
s tractus solitarii could be inhibited by glutamate receptor blockade. On t
he other hand, nitric oxide synthase (NOS) inhibitor attenuated the cardiov
ascular effects of glutamate. Thus, NO and glutamatergic systems appear to
interact in central cardiovascular regulation. The present study examined w
hether NO and glutamate may affect each other's release/production in the n
ucleus tractus solitarii. A microdialysis probe was implanted into the nucl
eus tractus solitarii of male Sprague-Dawley rats, and the changes in the e
xtracellular levels of glutamate and NO were determined by high performance
liquid chromatography coupled with electrochemical detection and an NO ana
lyzer, respectively. The results showed that NO solution elicited > 10 fold
increases in the extracellular level of glutamate, which returned to norma
l 60 min after the end of NO perfusion. The NO donor N-acetyl-penicillamine
(SNAP) had an effect similar to NO solution. Furthermore, the glutamate le
vel was reduced to 61% of basal value by perfusion with the NOS inhibitor,
N-G-monomethyl-L-arginine (L-NMMA). When glutamate receptor agonist N-methy
l-D-aspartic acid (NMDA) or alpha -amino-3-hydroxy-5-methylixoxazole-3-prop
ionic acid (AMPA) was administered into the nucleus tractus solitarii, the
extracellular NO level was increased by 70-100%, whereas glutamate receptor
antagonists (MK-801 hydrogen maleate and 6-cyano-7-nitroquinoxaline-2,3-di
one (CNQX)) did not alter the basal levels of NO. These results suggest tha
t NO and glutamate may enhance each other's release/production in the nucle
us tractus solitarii. This reciprocal regulation of NO and glutamate may he
important in central cardiovascular control in the nucleus tractus solitar
ii. (C) 2000 Elsevier Science B.V. All rights reserved.